When Two Strands Are Better Than One: The Mediators and Modulators of the Cellular Responses to Double-Stranded RNA

Virology

Volumn 219, Issue 2, 1996, Pages 339-349

  Jacobs, Bertram L ^a   Langland, Jeffrey O ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; DOUBLE STRANDED RNA; PROTEIN KINASE R; PROTEIN SERINE THREONINE KINASE; VIRUS PROTEIN; VIRUS RNA;

ANIMAL; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; APOPTOSIS; CARCINOGENESIS; GENE EXPRESSION; IMMUNE RESPONSE; INTERFERON INDUCTION; NONHUMAN; PRIORITY JOURNAL; RNA VIRUS; VIRUS CELL INTERACTION;

2',5'-OLIGOADENYLATE SYNTHETASE; ANIMALS; EIF-2 KINASE; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RNA, DOUBLE-STRANDED; RNA, VIRAL; VIRAL PROTEINS;

EID: 0030585155     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1996.0259     Document Type: Article

References (173)

1. Aloni, Y. (1972). Extensive symmetrical transcription of simian virus 40 DNA in virus-yielding cells. Proc. Natl. Acad. Sci. USA 69, 2402-2409.
2. Baglioni, C., Maroney, P. A., and West, D. K. (1979). 2′5′Oligo(A) polymerase activity and inhibition of viral RNA synthesis in interferon-treated HeLa cells. Biochemistry 18, 1765-1770.
3. Baier, L., Shors, T., Shors, S. T., and Jacobs, B. L. (1993). The mouse phosphotyrosine immunoreactive kinase, TIK, is indistinguishable from the double-stranded RNA-dependent, interferon-inducible protein kinase, PKR. Nucleic Acids Res. 21, 4830-4835.
4. Barber, G. N., Thompson, S., Lee, T. G., Strom, T., Jagus, R., Darveau, A., and Katze, M. G. (1994). The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratri-copeptide repeat protein with oncogenic properties. Proc. Natl. Acad. Sci. USA 91, 4278-4282.
5. Bayliss, C. D., and Condit, R. C. (1993). Temperature-sensitive mutants in the vaccinia virus A18R gene increase double-stranded RNA synthesis as a result of aberrant viral transcription. Virology 194, 254-262.
6. Beattie, E., Denzler, K., Tartaglia, J., Paoletti, E., and Jacobs, B. L. (1995a). Reversal of the interferon-sensitive phenotype of an E3L-minus vaccinia virus by expression of the reovirus S4 gene. J. Virol. 69, 499-505.
7. Beattie, E., Kaufman, E., Martinez, H., Perkus, M., Jacobs, B. L., Paoletti, E., and Tartaglia, J (1995b). Host range restriction of vaccinia virus E3L-specific deletion mutants. Virus Genes, in press.
8. Beattie, E., Tartaglia, J., and Paoletti, E. (1991). Vaccinia virus-encoded elF-2α homologue abrogates the antiviral effect of interferon. Virology 183, 419-422.
9. Benedetti, A. D., Pytel, B. A., and Baglioni, C. (1987). Loss of (2′-5′) oligoadenylate synthetase activity by production of anti-sense RNA results in lack of protection by interferon from viral infections. Proc. Natl. Acad. Sci. USA 84, 658-662.
10. Berry, M. J., Knutson, G. S., Laskey, S. R., Munemitsu, S. M., and Samuel, C. E. (1985). Mechanism of action of interferon. Purification and substrate specificities of the double-stranded RNA-dependent protein kinase from untreated and interferon-treated mouse fibroblasts. J Biol. Chem. 260, 11240-11247.
11. Bhat, R. A., and Thimmappaya, B. (1983). Two small RNAs encoded by Epstein-Barr virus can functionally substitute for the virus-associated RNAs in the lytic growth of adenovirus 5. Proc. Natl. Acad. Sci. USA 80, 4789-4793.
12. n-dependent endonucleases of different molecular mass. Eur. J. Biochem. 179, 595-602.
13. Bischoff, J. R., and Samuel, C. E. (1989). Activation of the human P1/elF-2 protein kinase by individual s-class mRNAs: s1 mRNA is a potent activator relative to s4 mRNA. Virology 172, 106-115.
14. Boone, R. F., Parr, R. P., and Moss, B. (1979). Intermolecular duplexes formed from polyadenylated vaccinia virus RNA. J. Virol. 30, 365-374.
15. Carroll, K., Elroy Stein, Q., Moss, B., and Jagus, R. (1993). Recombinant vaccinia virus K3L gene product prevents activation of double-stranded RNA-dependent, initiation factor 2 alpha-specific protein kinase. J. Biol. Chem. 268, 12837-12842.
16. Cattaneo, R. (1994). Biased (A- > I) hypermutation of animal RNA virus genomes. Curr. Opin. Genet. Dev. 4, 895-900.
17. Cattaneo, R., and Billeter, M. A. (1992). Mutations and A/I hypermutations in measles virus persistent infections. Curr. Top. Microbiol. Immunol. 176, 63-74.
18. Chang, H.-W., and Jacobs, B. L. (1993). Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA. Virology 194, 537-547.
19. Chang, H.-W., Uribe, L. H., and Jacobs, B. L. (1995). Rescue of vaccinia virus lacking the E3L gene by mutants of E3L. J. Virol. 69, 6605-6608.
20. Chang, H.-W., Watson, J, and Jacobs, B. L. (1992). The vaccinia virus E3L gene encodes a double-stranded RNA-binding protein with inhibitory activity for the interferon-induced protein kinase. Proc. Natl. Acad. Sci. USA 89, 4825-4829.
21. Chebath, J., Benech, P., Hovanessian, A., Galabru, J., and Revel, M. (1987a). Four different forms of interferon-induced 2′,5′-oligo(A) synthetase identified by immunoblotting in human cells. J. Biol. Chem. 262, 3852-3857.
22. Chebath, J., Benech, P., Revel, M., and Vigneron, M. (1987b). Constitutive expression of (2′-5′) oligo A synthetase confers resistance to picornavirus infection. Nature 330, 587-588.
23. Clarke, P. A., and Mathews, M. B. (1995). Interactions between the double-stranded RNA binding motif and RNA: Definition of the binding site for the interferon-induced protein kinase DAI (PKR) on adenovirus VA RNA. RNA 1, 7-20.
24. Clarke, P. A., Pe'ery, T., Ma, Y., and Mathews, M. B. (1994). Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI. Nucleic Acids Res. 22, 4364-4374.
25. Clarke, P. A., Schwemmle, M., Schickinger, J., Hilse, K., and Clemens, M. J. (1991). Binding of Epstein-Barr virus small RNA EBER1 to the double-stranded RNA-activated protein kinase DAI. Nucleic Acids Res. 19, 243-248.
26. Clemens, M. J., Laing, K. G., Jeffrey, I. W., Schofield, A., Sharp, T. V., Elia, A., Matys, V., James, M. C., and Tilleray, V. J. (1994). Regulation of the interferon-inducible elF-2 alpha protein kinase by small RNAs. Biochimie 76, 770-778.
27. Colby, C., and Duesberg, P. H. (1969). Double-stranded RNA in vaccinia virus-infected cells. Nature 222, 940-944.
28. Colby, C., Jurale, C., and Kates, J. R. (1971). Mechanism of synthesis of vaccinia virus double-stranded ribonucleic acid in vivo and in vitro. J. Virol. 7, 71-76.
29. Crum, C. J., Hiddinga, H. J., and Roth, D. A. (1988). Tobacco mosaic virus infection stimulates the phosphorylation of a plant protein associated with double-stranded RNA-dependent protein kinase activity. J. Biol. Chem. 263, 13440-13443.
30. 67) and its possible role in the inhibition of elF-2 kinase-catalyzed phosphorylation of the elF-2α-subunit. J. Biol. Chem. 264, 20620-20624.
31. Davies, M. V., Chang, H. W., Jacobs, B. L., and Kaufman, R. J. (1993). The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67, 1688-1692.
32. Davies, M. V., Elroy Stein, Q., Jagus, R, Moss, B., and Kaufman, R. J. (1992). The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 1943-1950.
33. Davies, M. V., Furtado, M., Hershey, J. W., Thimmappaya, B., and Kaufman, R. J. (1989). Complementation of adenovirus virus-associated RNA I gene deletion by expression of a mutant eukaryotic translation initiation factor. Proc. Natl. Acad. Sci. USA 86, 9163-9167.
34. Denzler, K., and Jacobs, B. L. (1994). Site-directed mutagenic analysis of reovirus σ3 binding to dsRNA. Virology 204, 190-199.
35. Desai, S. Y., Patel, R. C., Sen, G. C., Malhotra, P., Ghadge, G. D., and Thimmapaya, B. (1995). Activation of interferon-inducible 2′-5′ oligoadenylate synthetase by adenoviral VAI RNA. J. Biol. Chem. 270, 3454-3461.
36. Donze, Q., Jagus, R., Koromilas, A. E., Hershey, J. W., and Sonenberg, N. (1995). Abrogation of translation initiation factor elF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J 14, 3828-3834.
37. Duesberg, P. H., and Colby, C. (1969). On the biosynthesis and structure of double stranded RNA in vaccinia virus-infected cells. Proc. Natl. Acad. Sci. USA 64, 393-403.
38. Edery, I., Petryshyn, R., and Sonenberg, N. (1989). Activation of double-stranded RNA-dependent kinase (dsl) by the TAR region of HIV-1: A novel translational control mechanism. Cell 56, 303-312.
39. Enami, K., Sato, T. A., Nakada, S., and Enami, M. (1994). Influenza Virus NS1 Protein Stimulates Translation of the M1 Protein. J. Virol. 68, 1432-1437.
40. Farrell, P. J., Balkow, K., Hunt, T., Jackson, R. J., and Trachsel, H. (1977). Phosphorylation of initiation factor elF-2 and control of reticulocyte protein synthesis. Cell 11, 187-200.
41. Feng, G. S., Chong, K., Kumar, A., and Williams, B. R. (1992). Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proc. Natl. Acad. Sci. USA 89, 5447-5451.
42. Floyd-Smith, G., Sattery, E., and Lengyel, P. (1981). Interferon action: RNA cleavage pattern of a (2′-5′')oligoadenylate-dependent endonuclease. Science 212, 1030-1032.
43. Furtado, M. R., Subramanian, S., Bhat, R. A. Fowlkes, D. M., Safer, B., and Thimmappaya, B. (1989). Functional dissection of adenovirus VAI RNA. J. Virol. 63, 3423-3434.
44. Galabru, J., Katze, M. G., Robert, N., and Hovanessian, A. G. (1989). The binding of double-stranded RNA and adenovirus VAI RNA to the interferon-induced protein kinase. Eur. J. Biochem. 178, 581-589.
45. Gatignol, A., Buckler, C., and Jeang, K. T. (1993). Relatedness of an RNA-binding motif in human immunodeficiency virus type 1 TAR RNA-binding protein TRBP to human P1/dsl kinase and Drosophila staufen. Mol. Cell. Biol. 13, 2193-2202.
46. Gatignol, A., Buckler, C., White, A., Berkhout, B., and Jeang, K. T. (1991). Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251, 1597-1600.
47. Ghadge, G. D., Malhotra, P., Furtado, M. R., Dhar, R., and Thimmapaya, B. (1994). In vitro analysis of virus-associated RNA I (VAI RNA): Inhibition of the double-stranded RNA-activated protein kinase PKR by VAI RNA mutants correlates with the in vivo phenotype and the structural integrity of the central domain. J. Virol. 68, 4137-4151.
48. Ghosh, S. K., Kusari, J., Bandyopadhyay, S. K., Samanta, H., Kumar, R., and Sen, G. C. (1991). Cloning, sequencing, and expression of two murine 2′-5′-oligoadenylate synthetases: Structure-function relationship. J. Biol. Chem. 266, 15293-15299.
49. Giantini, M., and Shatkin, A. J. (1989). Stimulation of chloramphenicol acetyltransferase mRNA translation by reovirus capsid polypeptide σ3 in cotransfected COS cells. J. Virol. 63, 2415-2421.
50. Goebel, S. J., Johnson, G. P., Perkus, M. E., Davis, S. W., Winslow, J. P., and Paoletti, E. (1990). The complete DNA sequence of Vaccinia virus. Virology 179, 247-266.
51. Gott, P., Stohwasser, R., Schnitzler, P., Darai, G., and Bautz, E. K. (1993). RNA binding of recombinant nucleocapsid proteins of hantaviruses. Virology 194, 332-337.
52. Green, S. R., Manche, L., and Mathews, M. B. (1995). Two functionally distinct RNA-binding motifs in the regulatory domain of the protein kinase DAI. Mol. Cell. Biol. 15, 358-364.
53. Gribaudo, G., Lembo, D., Cavallo, G., Landolfo, S., and Lengyel, P. (1991). Interferon Action: Binding of Viral RNA to the 40-Kilodalton 2′-5′Oligoadenylate Synthetase in Interferon-Treated HeLa Cells Infected with Encephalomyocarditis Virus. J. Virol. 65, 1748-1757.
54. Grun, J., Kroon, E., Zoller, B., Krempien, U., and Jungwirth, C. (1987). Reduced steady-state levels of vaccinia virus-specific early mRNAs in interferon-treated chick embryo fibroblasts. Virology 158, 28-33.
55. Gunnery, S., Green, S. R., and Mathews, M. B. (1992). Tat-responsive region RNA of human immunodeficiency virus type 1 stimulates protein synthesis in vivo and in vitro: Relationship between structure and function. Proc. Natl. Acad. Sci. USA 89, 11557-11561.
56. Gunnery, S., Rce, A. P., Robertson, H. D., and Mathews, M. B. (1990). Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase. Proc. Natl. Acad. Sci. USA 87, 8687-8691.
57. Hassel, B. A., Zhou, A., Sotomayor, C., Maran, A., and Silverman, R. H. (1993). A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliterative and antiviral effects of Interferon. EMBO J. 12, 3297-3304.
58. Hatada, E., and Fukuda, R. (1992). Binding of influenza A virus NS1 protein to dsRNA in vitro. J. Gen. Virol. 73, 3325-3329.
59. Hatada, E., Takizawa, T., and Fukuda, R. (1992). Specific binding of influenza A virus NS1 protein to the virus minus-sense RNA in vitro. J. Gen. Virol. 73, 17-25.
60. Henry, G. L., McCormack, S. J., Thomis, D. C., and Samuel, C. E. (1994). Mechanism of Interferon action. Translational control and the RNA-dependent protein kinase (PKR): Antagonists of PKR enhance the translational activity of mRNAs that include a 161 nucleotide region from reovirus S1 mRNA. J. Biol. Regul. Homeost. Agents 8, 15-24.
61. Hiddinga, H. J., Crum, C. J., Hu, J., and Roth, D. A. (1988). Viroid-induced phosphorylation of a host protein related to the dsRNA-dependent protein kinase. Science 241, 451-453.
62. Hough, R. F., and Bass, B. L. (1994). Purification of the Xenopus laevis double-stranded RNA adenosine deaminase. J. Biol. Chem. 269, 9933-9939.
63. Huismans, H., and Joklik, W. K. (1976). Reovirus-coded polypeptides in infected cells: Isolation of two native monomeric polypeptides with affinity for single-stranded and double-stranded RNA, respectively. Virology 70, 411-424.
64. Ilson, D. H., Torrence, P. F., and Vilcek, J. (1986). Two molecular weight forms of human 2′,5′-oligoadenylate synthetase have different activation requirements. J. Interferon Res. 6, 5-12.
65. Imani, F., and Jacobs, B. L. (1988). Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 σ3 protein. Proc. Natl. Acad. Sci. USA 85, 7887-7891.
66. Ito, T., Jagus, R., and May, W. S. (1994). Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA 91, 7455-7459.
67. Jacobs, B. L., and Ferguson, R. E. (1991). Reovirus serotypes 1 and 3 differ in their sensitivity to interferon. J. Virol. 65, 5102-5104.
68. Jacobs, B. L., and Imani, F. (1988). Histone proteins inhibit activation of the interferon-induced protein kinase by binding to double-stranded RNA. J. Interferon Res. 8, 821-830.
69. Jagus, R., and Gray, M. M. (1994). Proteins that interact with PKR Biochimie 76, 779-791.
70. Jaquemont, B., and Roizman, B. (1975). RNA synthesis in cells infected with herpes simplex virus. X. Properties of viral symmetric transcripts and of double-stranded RNA prepared from them. J. Virol. 15, 707-713.
71. Jeffrey, I. W., Kadereit, S., Meurs, E. F., Metzger, T., Bachmann, M., Schwemmle, M., Hovanessian, A. G., and Clemens, M. J. (1995). Nuclear localization of the interferon-inducible protein kinase PKR in human cells and transfected mouse cells. Exp. Cell Res. 218, 17-27.
72. Jimenez Garcia, L. F., Green, S. R., Mathews, M. B., and Spector, D. L. (1993). Organization of the double-stranded RNA-activated protein kinase DAI and virus-associated VA RNAI in adenovirus-2-infected HeLa cells. J. Cell. Sci. 106, 11-22.
73. Judware, R., Li, J., and Petryshyn, R. (1993). Inhibition of the dsRNA-dependent protein kinase by a peptide derived from the human immunodeficiency virus type 1 Tat protein. J. Interferon Res. 13, 153-160.
74. Judware, R., and Petryshyn, R. (1992). Mechanism of action of a cellular inhibitor of the dsRNA-dependent protein kinase from 3T3-F442A cells. J. Biol. Chem. 267, 21685-21690.
75. Judware, R., and Petryshyn, R. (1991). Partial characterization of a cellular factor that regulates the double-stranded RNA-dependent elF-2 alpha kinase in 3T3-F442A fibroblasts. Mol. Cell. Biol. 11, 3259-3267.
76. r protein kinase to regulate its autophosphorylation and activity. EMBO J. 6, 689-697.
77. r protein kinase in a cell-free system. Mol. Cell. Biol. 11, 5497-5505.
78. Kerr, I. M., and Brown, R. E. (1978). pppA2′p5′A: An inhibitor of protein synthesis synthesized with an enzyme from interferon-treated cells. Proc. Natl. Acad. Sci. USA 75, 256-260.
79. Kim, U., Garner, T. L., Sanford, T., Speicher, D., Murray, J. M., and Nishikura, K. (1994). Purification and characterization of double-stranded RNA adenosine deaminase from bovine nuclear extracts. J. Biol. Chem. 269, 13480-13489.
80. Kim, U., and Nishikura, K. (1993). Double-stranded RNA adenosine deaminase as a potential mammalian RNA editing factor. Semin. Cell Biol. 4, 285-293.
81. Kimura, Takeuchi, M., Majde, J. A., Toth, L. A., and Krueger, J. M. (1992). The role of double-stranded RNA in induction of the acute-phase response in an abortive influenza virus infection model. J Infect. Dis. 166, 1266-1275.
82. Kitajewski, J., Schneider, R. J., Safer, B., Munemitsu, S. M., Samuel, C. E., Thimmappaya, B., and Shenk, T. (1986). Adenovirus VAI RNA antagonizes the antiviral action of interferon by preventing activation of the interferon-induced elF-2 kinase. Cell 45, 195-200.
83. Kohne, D. E., Levison, S. A., and Byers, M. J. (1977). Room temperature method for increasing the rate of DNA reassociation by many thousandfold: the phenol emulsion reassociation technique. Biochemistry 16, 5329-5341.
84. Koromilas, A. E., Roy, S., Barber, G. N., Katze, M. G., and Sonenberg, N. (1992). Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689.
85. Kostura, M., and Mathews, M. B. (1989). Purification and activation of the double-stranded RNA-dependent elF-2 kinase DAI. Mol. Cell. Biol. 9, 1576-1586.
86. Kumar, A., Haque, J., Lacoste, J. Hiscott, J, and Williams, B. R. (1994). Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA 91, 6288-6292.
87. r = 66,000 subunits. J. Biol. Chem. 267, 10729-10736.
88. Langland, J. Q., Pettiford, S. M., Jang, B., and Jacobs, B. L. (1994). Products of the porcine NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase, PKR. J. Virol. 68, 3821-3829.
89. Langland, J. Q., Song, J., Jacobs, B. L., and Roth, D. A. (1995). A plant-encoded analogue of PKR, the mammalian double-stranded RNA-dependent protein kinase. Plant Physiol. 108, 1259-1267.
90. n synthetases specified by distinct mRNAs in Ehrlich ascites tumor cells treated with interferon. Cell 33, 95-102.
91. Lee, J. Y., Marshall, J. A., and Bowden, D. S. (1994a). Characterization of rubella virus replication complexes using antibodies to double-stranded RNA. Virology 200, 307-312.
92. Lee, S. B., and Esteban, M. (1994). The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis. Virology 199, 491-496.
93. Lee, T. G., and Katze, M. G. (1994). Cellular inhibitors of the interferon-induced, dsRNA-activated protein kinase. Prog. Mol. Subcell. Biol. 14, 48-65.
94. Lee, T. G., Tang, N., Thompson, S., Miller, J., and Katze, M. G. (1994b). The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol. Cell. Biol. 14, 2331-2342.
95. Lee, T. G., Tomita, J., Hovanessian, A. G., and Katze, M. G. (1992). Characterization and regulation of the 58,000-dalton cellular inhibitor of the interferon-induced, dsRNA-activated protein kinase. J Biol. Chem. 267, 14238-14243.
96. r 68,000 from influenza virus-infected cells. Proc. Natl. Acad. Sci. USA 87, 6208-6212.
97. Lemay, G., and Danis, C. (1994). Reovirus lambda 1 protein: Affinity for double-stranded nucleic acids by a small ami no-terminal region of the protein independent from the zinc finger motif. J. Gen. Virol. 75, 3261-3266.
98. Lerner, M. R., Andrews, N. C., Miller, G., and Steitz, J. A. (1981). Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 78, 805-809.
99. Levin, D., and London, I. M. (1978). Regulation of protein synthesis: activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proc. Natl. Acad. Sci. USA 75, 1121-1125.
100. Li, J., and Petryshyn, R. A. (1991). Activation of the double-stranded RNA-dependent elF-2 alpha kinase by cellular RNA from 3T3-F442A cells. Eur. J. Biochem. 195, 41-48.
101. Lloyd, R. M., and Shatkin, A. J. (1992). Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2. J. Virol. 66, 6878-6884.
102. Lu, Y., Wambach, M., Katze, M. G., and Krug, R. M. (1995). Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214, 222-228.
103. Mabrouk, T., Danis, C., and Lemay, G. (1995). Two basic motifs of reovirus σ3 protein are involved in double-stranded RNA binding. Biochem. Cell Biol., in press.
104. Maitra, R. K., McMillan, N. A., Desai, S., McSwiggen, J., Hovanessian, A. G., Sen, G., Williams, B. R., and Silverman, R. H. (1994). HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204, 823-827.
105. Majde, J. A., Brown, R. K., Jones, M. W., Dieffenbach, C. W., Maitra, N., Krueger, J. M., Cady, A. B., Smitka, C. W., and Maassab, H. F. (1991). Detection of toxic viral-associated double-stranded RNA (dsRNA) in influenza-infected lung. Microbiol. Pathogen. 10, 105-115.
106. Maran, A., Maitra, R. K., Kumar, A., Dong, B., Xiao, W., Li, G., Williams, B. R., Torrence, P. F., and Silverman, R. H. (1994). Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras. Science 265, 789-792.
107. Maran, A., and Mathews, M. B. (1988). Characterization of the double-stranded RNA implicated in the inhibition of protein synthesis in cells infected with a mutant adenovirus defective for VA RNA. Virology 164, 106-113.
108. Marcus, P. I., and Sekellick, M. J. (1977). Defective interfering particles with covalently linked [+/-]RNA induce interferon. Nature 266, 815-819.
109. Marie, I., and Hovanessian, A. G. (1992). The 69-kDa 2-5A synthetase is composed of two homologous and adjacent functional domains. J. Biol. Chem. 267, 9933-9939.
110. Marie, I., Svab, J., Robert, N., Galabru, J., and Hovanessian, A. G. (1990). Differential expression and distinct structure of 69- and 100kDa forms of 2-5A synthetase in human cells treated with interferon. J. Biol. Chem. 265, 18601-18607.
111. Mathews, M. B., and Shenk, T. (1991). Adenovirus virus-associated RNA and translation control. J. Virol. 65, 5657-5662.
112. McCormack, S. J., Ortega, L. G., Doohan, J. P., and Samuel, C. E. (1994). Mechanism of interferon action motif I of the interferon-induced, RNA-dependent protein kinase (PKR) is sufficient to mediate RNA-binding activity. Virology 198, 92-99.
113. D values for VAI and TAR RNAs. Virology 206, 511-519.
114. McCormack, S. J., Thomis, D. C., and Samuel, C. E. (1992). Mechanism of interferon action: identification of a RNA binding domain within the N-terminal region of the human RNA-dependent P1/elF-2 alpha protein kinase. Virology 188, 47-56.
115. McMillan, N. A., Carpick, B. W., Hollis, B., Toone, W. M., Zamanian Daryoush, M., and Williams, B. R. (1995). Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR. J. Biol. Chem. 270, 2601-2606.
116. Mellits, K. H., Kostura, M., and Mathews, M. B. (1990). Interaction of adenovirus VA RNA1 with the protein kinase DAI: Nonequivalence of binding and function. Cell 61, 843-852.
117. Mellits, K. H., and Mathews, M. B. (1988). Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI. EMBO J. 7, 2849-2859.
118. Meurs, E. F., Galabru, J. Barber, G. N., Katze, M. G., and Hovanessian, A. G. (1993). Tumor suppressor function of the interferon-induced double-stranded activated protein kinase. Proc. Natl. Acad. Sci. USA 232-236.
119. Meurs, E. F., Watanabe, Y., Kadereit, S., Barber, G. N., Katze, M. G., Chong, K., Williams, B. R. G., and Hovanessian, A. G. (1992). Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis growth. J. Virol. 66, 5805-5814.
120. Miller, J. E., and Samuel, C. E. (1992). Proteolytic cleavage of the reovirus σ3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region. J Virol. 66, 5347-5356.
121. Morrissey, L. M., and Kirkegaard, K. (1991). Regulation of a double-stranded RNA modification activity in human cells. Mol. Cell. Biol. 11, 3719-3725.
122. Moss, B. (1990). Poxviridae and their replication. In "Fundamental Virology" (B. N. Fields, D. M. Knipe, et al., Eds.), 2nd ed., pp. 953-985. Raven Press, New York.
123. Mundschau, L. J., and Faller, D. V. (1994). Endogenous inhibitors of the dsRNA-dependent elF-2 alpha protein kinase PKRin normal and ras-transformed cells. Biochimie 76, 792-800.
124. Mundschau, L. J., and Faller, D. V. (1992). Oncogenic ras induces an inhibitor of double-stranded RNA-dependent eukaryotic initiation factor 2 alpha-kinase activation. J. Biol. Chem. 267, 23092-23098.
125. Mundschau, L. J., and Faller, D. V. (1995). Platelet-derived growth factor signal transduction through the interferon-inducible kinase PKR Immediate early gene induction. J. Biol. Chem. 270, 3100-3106.
126. Nilsen, T. W., Maroney, P. A., and Baglioni, C. (1982). Synthesis of (2′-5′)oligoadenylate and activation of an endoribonuclease in interferon-treated HeLa cells infected with reovirus. J. Virol. 42, 1039-1045.
127. Nishikura, K. (1992). Modulation of double-stranded RNAs in vivo by RNA duplex unwindase. Ann. N.Y. Acad. Sci. 660, 240-250.
128. O'Connell, M. A., and Keller, W. (1994). Purification and properties of double-stranded RNA-specific adenosine deaminase from calf thymus. Proc. Natl. Acad. Sci. USA 91, 10596-10600.
129. Offermann, M. K., Zimring, J., Mellits, K. H., Hagan, M. K., Shaw, R., Medford, R. M., Mathews, M. B., Goodbourn, S., and Jagus, R. (1995). Activation of the double-stranded-RNA-activated protein kinase and induction of vascular adhesion molecule-1 by poly(l).poly(C) in endothelial cells. Eur. J. Biochem. 232, 28-36.
130. Park, H., Davies, M. V., Langland, J. O., Chang, H.-W., Nam, Y. S., Tartaglia, J., Paoletti, E., Jacobs, B. L., Kaufman, R. J., and Venkatesan, S. (1994). A cellular protein that binds several structured viral RNAs is an inhibitor of the interferon induced PKR protein kinase in vitro and in vivo. Proc. Natl. Acad. Sci. USA 91, 4713-4717.
131. Patel, R. C., and Sen, G. C. (1992). Identification of the double-stranded RNA-binding domain of the human interferon-inducible protein kinase. J. Biol. Chem. 267, 7671-7676.
132. Patel, R. C., Stanton, P., McMillan, N. M., Williams, B. R., and Sen, G. C. (1995). The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo. Proc. Natl. Acad. Sci. USA 92, 8283-8287.
133. Pe'ery, T., Mellits, K. H., and Mathews, M. B. (1993). Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure. J. Virol. 67, 3534-3543.
134. Pestka, S., Langer, J. A., Zoon, K. C., and Samuel, C. E. (1987). Interferons and their actions. Annu. Rev. Biochem. 56, 727-777.
135. Pettersson, U., and Philipson, L. (1974). Synthesis of complementary RNA sequences during productive adenovirus infection. Proc. Natl. Acad. Sci. USA 71, 488-491.
136. Prostko, C. R., Dholakia, J. N., Brostrom, M. A., and Brostrom, C. O. (1995). Activation of the double-stranded RNA-regulated protein kinase by depletion of endoplasmic reticular calcium stores. J. Biol. Chem. 270, 6211-6215.
137. Qian, X.-Y., Chien, C.-Y., Lu, Y., Montelione, G. T., and Krug, R. M. (1995). An amino-terminal polypeptide fragment of the influenza virus NS1 protein possesses specific RNA-binding activity and largely helical backbone structure. RNA 1, 948-956.
138. Rajan, P., Swaminathan, S., Zhu, J., Cole, C. N., Barber, G., Tevethia, M. J., and Thimmapaya, B. (1995). A novel translational regulation function for the simian virus 40 large-T antigen gene. J. Virol. 69, 785-795.
139. Ray, M. K., Chakraborty, A., Datta, B., Chattopadhyay, A., Saha, D., Bose, A., Kinzy, T. G., Wu, S., Hileman, R. E., Merrick, W. C., and Gupta, N. K. (1993). Characteristics of the eukaryotic initiation factor 2 associated 67-kDa polypeptide. Biochemistry 32, 5151-5159.
140. Ray, M. K., Datta, B., Chakraborty, A., Chattopadhyay, A., Meza Keuthen, S., and Gupta, N. K. (1992). The eukaryotic initiation factor 2-associated 67-kDa polypeptide (p67) plays a critical role in regulation of protein synthesis initiation in animal cells. Proc. Natl. Acad. Sci. USA 89, 539-543.
141. Romano, P. R. Green, S. R., Barber, G. N., Mathews, M. B., and Hinnebusch, A. G. (1995). Structural requirements for double-stranded RNA binding, dimerization, and activation of the human elF-2 alpha kinase DAI in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 365-378.
142. n synthetase induce by recombinant human interferon-α and interferon-γ. Interferon Res. 8, 275-282.
143. Roth, D. A., and He, X. (1994). Viral-dependent phosphorylation of a dsRNA-dependent kinase. Prog. Mol. Subcell. Biol. 14, 28-47.
144. Samuel, C. E. (1979). Mechanism of Interferon action: phosphorylation of protein synthesis initiation factor elF-2 in interferon-treated human cells by a ribosome-associated kinase possessing site specificity similar to hemin-regulated rabbit reticulocyte kinase. Proc. Natl. Acad. Sci. USA 76, 600-604.
145. Saunders, M. E., Gewert, D. R., Tugwell, M. E., McMahon, M., and Williams, B. R. G. (1985). Human 2-5A synthetase: Characterization of a novel cDNAand corresponding gene structure. EMBO J. 4, 1761-1768.
146. Schiff, L. A., and Fields, B. N. (1990). Reoviruses and their replication. In "Fundamental Virology" (B. N. Fields, D. M. Knipe, et al., Eds.), 2nd ed., pp. 583-618. Raven Press, New York.
147. Schiff, L. A., Nibert, M. L., Co, M. S., Brown, E. G., and Fields, B. N. (1988). Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein σ3. Mol. Cell. Biol. 8, 273-283.
148. Schmedt, C., Green, S. R., Manche, L., Taylor, D. R., Ma, Y., and Mathews, M. B. (1995). Functional characterization of the RNA-binding domain and motif of the double-stranded RNA-dependent protein kinase DAI (PKR). J. Mol. Biol. 249, 29-44.
149. Schreck, R., Reber, P., and Baeuerle, P. A. (1991). Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10, 2247-2258.
150. Schroder, H. C., Ugarkovic, D., Wenger, R., Reuter, P., Okamoto, T., and Muller, W. E. G. (1990). Binding of tat protein to TAR region of human immunodeficiency virus type 1 blocks TARmediated activation of (2′-5′) oligoadenylate synthetase. AIDS Res. Hum. Retroviruses 6, 659-672.
151. Schroder, H. C., Wenger, R., Kuchino, Y., and Muller, W. E. G. (1989). Modulation of nuclear matrix-associated (2′-5′) oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J. Biol. Chem. 264, 5669-5673.
152. Seliger, L. S., Giantini, M., and Shatkin, A. J. (1992). Translational effects and sequence comparisons of the three serotypes of the reovirus S4 gene. Virology 187, 202-210.
153. Sen, G. C., and Lengyel, P. (1992). The Interferon System: A Bird's Eye View Of Its Biochemistry. J. Biol. Chem. 267, 5017-5020.
154. Sengupta, D. N., and Silverman, R. H. (1989). Activation of interferon-regulated, dsRNA-dependent enzymes by human immunodeficiency virus-1 leader RNA. Nucleic Acids Res. 17, 969-979.
155. Sharmeen, L., Bass, B., Sonenberg, N., Weintraub, H., and Groudine, M. (1991). Tat-dependent adenosine-to-inosine modification of wild-type transactivation response RNA. Proc. Natl. Acad. Sci. USA 88, 8096-8100.
156. Sharp, T. V., Schwemmle, M., Jeffrey, I., Laing, K., Mellor, H., Proud, C. G., Hilse, K., and Clemens, M. J. (1993). Comparative analysis of the regulation of the interferon-inducible protein kinase PKR by Epstein-Barr virus
157. Sharpe, A. H., and Fields, B. N. (1982). Reovirus inhibition of cellular RNA and protein synthesis: Role of the S4 gene. Virology 122, 81-391.
158. Silverman, R. H., Jung, D. D., Nolan-Sorden, N. L., Dieffenbach, C. W., Kedar, V. P., and Sengupta, D. N. (1988). Purification and analysis of murine 2-5A-dependent RNase. J. Biol. Chem. 263, 7336-7341.
159. Silverman, R. H., and Sengupta, D. N. (1990). Translational regulation by HIV leader RNA, TAT, and interferon-inducible enzymes. J. Exp. Pathol. 5, 69-77.
160. Simpson, D. A., and Condit, R. C. (1994). The vaccinia virus A18R protein plays a role in viral transcription during both the early and the late phases of infection. J. Virol. 68, 3642-3649.
161. St. Johnston, D., Brown, N. H., Gall, J. G., and Jantsch, M. (1993). A conserved double-stranded RNA binding domain. Proc. Natl. Acad. Sci. USA 89, 10979-10983.
162. Swaminathan, S., Huneycutt, B. S., Reiss, C. S., and Kieff, E. (1992). Epstein-Barr virus-encoded small RNAs (EBERs) do not modulate interferon effects in infected lymphocytes. J. Virol. 66, 5133-5136.
163. Takizawa, T., Fukuda, R., Miyawaki, T., Ohashi, K., and Nakanishi, Y. (1995). Activation of the Apoptotic Fas Antigen-Encoding Gene upon Influenza Virus Infection Involving Spontaneously Produced Beta-Interferon. Virology 209, 288-296.
164. Thimmappaya, B. C., Weinberger, C., Schneider, R. J., and Shenk, T. (1982). Adenovirus VAI RNA is required for efficient translation of viral mRNAs at late times after infection. Cell 31, 543-551.
165. Thomis, D. C., and Samuel, C. E. (1995). Mechanism of interferon action: Characterization of the intermolecular autophosphorylation of PKR, the interferon-inducible, RNA-dependent protein kinase. J. Virol. 69, 5195-5198.
166. Toczyski, D. P., Matera, A. G., Ward, D. C., and Steitz, J. A. (1994). The Epstein-Barr virus (EBV) small RNA EBER1 binds and relocalizes ribosomal protein L22 in EBV-infected human B lymphocytes. Proc. Natl. Acad. Sci. USA 91, 3463-3467.
167. Wathelet, M., Moutschen, S., Cravador, A., Dewit, L., Defilippi, P., Huez, G., and Content, J. (1986). Full-length sequence and expression of the 42 kDa 2-5A synthetase induced by human interferon. FEBS Lett. 196, 113-120.
168. Watson, J., Chang, H.-W., and Jacobs, B. L. (1991). Characterization of a vaccinia virus-induced dsRNA-binding protein that may be the inhibitor of the dsRNA-dependent protein kinase. Virology 185, 206-216.
169. Whitaker-Dowling, P., and Youngner, J. S. (1983). Vaccinia rescue of VSV from interferon-induced resistance: Reversal of translation block and inhibition of protein kinase activity. Virology 131, 128-136.
170. nA-dependent ribonuclease. Nature 289, 414-417.
171. Xiao, Q., Sharp, T. V., Jeffrey, I. W., James, M. C., Pruijn, G. J., van Venrooij, W. J., and Clemens, M. J. (1994). The La antigen inhibits the activation of the interferon-inducible protein kinase PKR by sequestering and unwinding double-stranded RNA. Nucleic Acids Res. 22, 2512-2518.
172. nsynthetase. J. Biol. Chem. 256, 9324-9328.
173. Yuwen, H., Cox, J. H., Yewdell, J. W., Bennink, J. R., and Moss, B. (1993). Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology 195, 732-744.